Skip to Content
Merck
CN

SML3901

Crenolanib trifluoroacetate

≥98% (HPLC)

Synonym(s):

1-[2-[5-[(3-Methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine trifluoroacetate, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine trifluoroacetate, ARO 00 trifluoroacetate2, CP 868596 trifluoroacetate, CP868596 trifluoroacetate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C26H29N5O2 · xC2HF3O2
Molecular Weight:
443.54 (free base basis)
UNSPSC Code:
12352200
NACRES:
NA.21
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

SMILES string

N6(CCC(CC6)N)c1c2nc(ccc2ccc1)[n]3c4c(nc3)cc(cc4)OCC5(COC5)C

InChI

1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3

InChI key

DYNHJHQFHQTFTP-UHFFFAOYSA-N

Biochem/physiol Actions

Crenolanib is an orally bioavailable, potent and selective platelet-derived growth factor receptor (PDGFR) tyrosine kinase inhibitor. Also crenolanib potently inhibits FLT3.
Platelet-derived growth factor receptor (PDGFR) tyrosine kinase inhibitor

Disclaimer

Hygroscopic


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library